CRSP
CRISPR Therapeutics AG
NASDAQ · Healthcare · Biotechnology · CH
$51.78
+3.57%Leverage
- Debt / equity
- 0.47x
- Net debt / equity
- 0.36x
- Debt / assets
- 0.31x
- Debt / EBITDA
- -1.70x
- Net debt / EBITDA
- -1.28x
Liquidity & coverage
- Current ratio
- 16.21x
- Quick ratio
- 16.21x
- Cash ratio
- 16.12x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $2.1B
Cash & dividend
- FCF / debt
- -0.49x
- Cash flow / debt
- -0.48x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026